AKTIP pseudogene 1 (AKTIPP1)

**AKTIP pseudogene 1 (AKTIPP1)** is a genomic DNA sequence that closely resembles the functional AKTIP gene but has accumulated mutations that render it nonfunctional for protein-coding; it is classified as a pseudogene[1][5][9]. Pseudogenes like AKTIPP1 do not encode active proteins and generally do not have well-defined biological activities, therapeutic roles, or drug interactions. In some cases, pseudogenes can have regulatory effects at the RNA level, but such roles are uncommon and not established for AKTIPP1[3][7]. **Clarification and misidentification**: - The **AKTIP gene** (not the pseudogene) encodes a ubiquitin E2 variant-like protein involved in vesicle trafficking, apoptosis, and cell signaling, and is known to play roles in certain cancers, but AKTIPP1 refers to a nonfunctional, noncoding DNA segment[2][4]. - If the therapeutic relevance or research interest is in the protein or targetable biology, **the correct target is AKTIP**, not AKTIPP1[2][4]. There is currently no robust evidence of AKTIPP1 as a drug target, disease biomarker, or safety concern. **Summary of pseudogene features**: - Pseudogenes arise from pre-existing genes but accumulate mutations and lose protein-coding ability[1][5][9]. - Some pseudogenes may exert regulatory effects on their parent genes through competitive RNA mechanisms, but such functions are exceptions, not the rule, and no such function is currently assigned to AKTIPP1[3]. **In summary:** AKTIP pseudogene 1 (AKTIPP1) is a pseudogene with no known functional protein product, biological activity, or therapeutic relevance. Its inclusion in a drug target database or therapeutic target list is likely incorrect. If your intent was to refer to a functional target, use "AKTIP (AKT interacting protein)" instead.